View a detailed overview of the ILLUMISITE™ fluoroscopic navigation technology and how it, combined with the CrossCountry™ transbronchial access tool, gives you the power to display position and access nodules — moving lung health technology forward.
Diagnostic screening systems
ILLUMISITE™ fluoroscopic navigation platform
The ILLUMISITE™ platform gives you the power to access nodules in the pulmonary tract.
Features
Experience the lung navigation platform that corrects for CT-to-body divergence.
The ILLUMISITE™ platform is designed to correct for CT-to-body divergence — the discrepancy between a static CT scan and the breathing lung — with real-time visualization that enhances image clarity, and adjusts to a dynamic environment.†,2,3
Biopsy with confidence.
The ILLUMISITE™ platform is clinically proven to help you accurately navigate lung nodules.†,‡,2,3,4 With its unique fluoroscopic navigation technology using digital tomosynthesis you’ll have greater confidence that you’re in the right spot before you biopsy.2,3
Maintain a bullseye view of the virtual target.
Ongoing guidance enables continued target alignment across multiple tool uses without needing to reinsert the locatable guide.†,3
More about the ILLUMISITE™ platform
Lung biopsies are challenging — the ILLUMISITE™ platform is helping to solve for that. (05:10)
Discover the ILLUMISITE™ platform. (02:32)
Hear what clinicians are saying about the ILLUMISITE™ platform. (06:34)
Related products
-
ILLUMISITE™ bronchoscope adapterThe ILLUMISITE™ bronchoscope adapters are used to attach an ILLUMISITE™ extended working channel to the working channel of a bronchoscope. -
ILLUMISITE™ endobronchial procedure kitThe ILLUMISITE™ endobronchial procedure kit includes the ILLUMISITE™ locatable guide and the ILLUMISITE™ extended working channel. -
ILLUMISITE™ patient sensor patchThe single-use ILLUMISITE™ patient sensor patch secures a patient sensor to the patient. Each procedure requires three sensor patches.
Risk statement
Not for use in pediatric patients or those with unstable hemodynamic status. Specific risks include but not limited to bleeding, pneumothorax, and respiratory failure. Please refer to instructions for use for complete contraindication and risk information.
† Based on evidence from a single-center prospective study including a total of 82 consecutive patients.
‡ Based on evidence from a single-center retrospective study including a total of 72 consecutive patients.
- Pritchett MA, Bhadra K, Calcutt M, Folch E. Virtual or reality: divergence between preprocedural computed tomography scans and lung anatomy during guided bronchoscopy. J Thorac Dis 2020;12(4):1595–1611.
- Pritchett MA, Bhadra K, Mattingley JS. Electromagnetic navigation bronchoscopy with tomosynthesis-based visualization and positional correction: three-dimensional accuracy as confirmed by cone-beam computed tomography. J Bronchology Interv Pulmonol. 2021; 28(1):10–20.
- Avasarala SK, Roller L, Katsis J, et al. Sight Unseen: Diagnostic Yield and Safety Outcomes of a Novel Multimodality Navigation Bronchoscopy Platform with Real-time Target Acquisition. Respiration . Published online September 03, 2021. doi: 10.1159/000518009.
- Dunn BK, Blaj M, Stahl J, Speicher J, Anciano C, Hudson S, Kragel EA, Bowling MR. Evaluation of electromagnetic navigational bronchoscopy using tomosynthesis-assisted visualization, intraprocedural positional correction and continuous guidance for evaluation of peripheral pulmonary nodules. J Bronchology Interv Pulmonol. 2023;30(1):16–23.